Neurocrine Biosciences Inc(NBIX)
100.18
Change: 0 (0)
As of Wed 10/06/2021 03:01 AM% Of Value
Growth
Value Per Share
:
:
:
1933.98
8.38
5.1800 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
Open | 91.75 | Dividend | 87 |
Close Price | 100.18 | DivYield | 0 % |
High | 97.625 | Growth | 0.0 |
Low | 91.36 | Growth% | 8.38 |
P/e | 363.053 | Volume | 448,265.0 |
P/b | -1.43 | Market Capital | 9.4 B |
Highest High | 75.46 | Lowest Low | 37.9 |
50 Days Moving Average | 82.78 (as of 21/07/2019) | 50 Days Moving Average Percentage | 19.697 (as of 21/07/2019 |
Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
Revenue | 161.6 M | 451.2 M | 788.0 M | 1.0 B | 1.1 B |
Cap Spending | -6.9 M | -24.7 M | -14.7 M | -10.9 M | -23.4 M |
Operating Expenses | 291.7 M | 409.4 M | 708.3 M | 872.8 M | 1.0 B |
Operating Cash Flow | -131.3 M | 36.8 M | 72.2 M | 163.0 M | 102.5 M |
Free Cash Flow | -101.2 M | 76.5 M | 137.3 M | 217.6 M | 233.1 M |
Free Cash Flow Per Share | -1.15 | 0.849 | 1.499 | 2.337 | 2.464 |
Total liabilities | 369.6 M | 388.4 M | 495.5 M | 412.3 M | 440.4 M |
Total cash | 259.2 M | 147.1 M | 115.4 M | 190.3 M | 340.8 M |
ROE% | -0.435 | 0.051 | 0.07 | 0.471 | 0.069 |
Outstanding Shares | 89.2 M | 90.8 M | 92.2 M | 93.9 M | 95.2 M |
P/E | -52.415 | 363.053 | 259.282 | 26.788 | 90.916 |
P/S | 46.226 | 16.985 | 12.177 | 10.432 | 7.187 |
Revenue USD | 161.6 M | 451.2 M | 788.0 M | 1.0 B | 1.1 B |
NO REPORTS FOR THIS STOCK |
Latest Searches
Stock | Close Price | %of value | Date |
---|